Tectonic Therapeutic | AVRO - Ebit


Tectonic Therapeutic reported $-22.33M in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
Celltrion KRW 301.04B 58.57B Sep/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Deva Holding AS TRY 820.88M 192.13M Sep/2023
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Karyopharm Therapeutics USD -26.28M 1.84M Sep/2024
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
MacroGenics USD 20.16M 55.51M Sep/2025
Malin Corporation EUR -1.1M 300K Dec/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Ovoca Bio EUR -5.65M 3.45M Jun/2022
Pfizer USD 4.65B 71M Dec/2025
Pharma Mar EUR -3.96M 28.11M Sep/2025
Qiagen NV USD 121.88M 19.18M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Takeda JPY 257.49B 568.56B Dec/2025
Tilray USD -20.01M 9.34M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025